Article
Myelodysplastic Syndromes: Updates and Nuances.
The Medical clinics of North America - 1 Mar 2017
Dao Kim-Hien T
Abstract excerpt
Myelodysplastic syndrome (MDS) is a heterogeneous, clonal stem cell disorder of the blood and marrow typically diagnosed based on the presence of persistent cytopenia(s), dysplastic cells, and genetic markers. Common issues that arise in the clinical management include difficulty confirming MDS diagnosis, lack of a standard approach with novel agents in MDS, and few prospective long-term, randomized controlled...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
